Pancreaticoduodenectomy for advanced gastric cancer with pancreaticoduodenal region involvement

World Journal of Gastroenterology

Volumn 14, Issue 21, 2008, Pages 3425-3429

  Wang, Xin Bao ^a   Yang, Li Tao ^a   Zhang, Ze Wei ^a   Guo, Jian Min ^a   Cheng, Xiang Dong ^a  

^a ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

Gastrectomy; Gastric cancer; Pancreaticoduodenectomy; Patients; Predictive factor

Indexed keywords

ETOPOSIDE; FLUOROURACIL; FOLINIC ACID;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; BODY WEIGHT DISORDER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREATICODUODENECTOMY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PROGNOSIS; SMALL INTESTINE CANCER; STOMACH CANCER; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT RESPONSE; WEIGHT REDUCTION;

EID: 54349111647     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.3425     Document Type: Article

References (23)

1. Itoh H, Oohata Y, Nakamura K, Nagata T, Mibu R, Nakayama F. Complete ten-year postgastrectomy follow-up of early gastric cancer. Am J Surg 1989; 158: 14-16
2. Lee JS, Douglass HO Jr. D2 dissection for gastric cancer. Surg Oncol 1997; 6: 215-225
3. Ikeguchi M, Oka S, Gomyo Y, Tsujitani S, Maeta M, Kaibara N. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer. Anticancer Res 2000; 20: 1285-1289
4. Pugliese R, Maggioni D, Berardi V, Scandroglio I, Pisani D, Mariani A, Di Lernia S, Valli C, Cocotta E. Extended (D2) lymphadenectomy in gastric cancer: a five year experience. Int Surg 2000; 85: 209-215
5. van de Velde CJ. Resection for gastric cancer in the community. Semin Oncol 2005; 32: S90-S93
6. Shchepotin IB, Chomy VA, Nauta RJ, Shabahang M, Buras RR, Evans SR. Extended surgical resection in T4 gastric cancer. Am J Surg 1998; 175: 123-126
7. Martin RC 2nd, Jaques DP, Brennan MF, Karpeh M. Extended local resection for advanced gastric cancer: increased survival versus increased morbidity. Ann Surg 2002; 236: 159-165
8. Okano K, Maeba T, Ishimura K, Karasawa Y, Goda F, wakabayashi H, Usuki H, Maeta H. Hepatic resection tor metastatic tumors from gastric cancer. Ann Surg 2002; 235: 86-91
9. Peng S, Mou Y, Cai X, Peng C. Binding pancreaticojejunostomy is a new technique to minimize leakage. Am J Surg 2002; 183: 283-285
10. Wilke H, Preusser P, Fink U, Achterrath W, Mayer HJ, Stahl M, Lenaz L, Meyer J, Siewert JR, Gerlings H. New developments in the treatment of gastric carcinoma. Cancer Treat Res 1991; 55: 363-373
11. Schulze-Bergkamen H, Zuna I, Teufel A, Stremmel W, Rudi J. Treatment of advanced gastric cancer with etoposide, folinic acid, and fluorouracil in the clinical setting: efficacy of therapy and value of serum tumor markers. Med Oncol 2002; 19: 43-53
12. Takeuchi K, Tsuzuki Y, Andol T, Sekihara M, Hara T, Yoshikawa M, Ohno Y, Kuwano H. Total gastrectomy with distal pancreatectomy and splenectomy for advanced gastric cancer. J Surg Res 2001; 101: 196-201
13. Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995; 333: 32-41
14. Kodama I, Takamiya H, Mizutani K, Ohta J, Aoyagi K, Kofuji K, Takeda J, Shirouzu K. Gastrectomy with combined resection of other organs for carcinoma of the stomach with invasion to adjacent organs: clinical efficacy in a retrospective study. J Am Cell Surg 1997; 184: 16-22
15. Iriyama K, Ohsawa T, Tsuchibashi T, Noji M, Miki C, Ilunga K, Suzuki H. Results of combined resection of invaded organs in patients with potentially curable, advanced gastric cancer. Eur J Surg 1994; 160: 27-30
16. Korenaga D, Okamura T, Baba H, Saito A, Sugimachi K. Results of resection of gastric cancer extending to adjacent organs. Br J Surg 1988; 75: 12-15
17. Ozaki H, Kinoshita T, Kosuge T, Yamamoto J, Shimada K, Inoue K, Koyama Y, Mukai K. An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas. Cancer 1996; 77: 2240-2245
18. Yonemura Y, Ooyama S, Matumoto H, Kamata T, Kimura H, Takegawa S, Kosaka T, Yamaguchi A, Miwa K, Miyazaki I. Pancreaticoduodenectomy in combination with right hemicolectomy for surgical treatment of advanced gastric carcinoma located in the lower half of the stomach. Int Surg 1991; 76: 226-229
19. Cho BC, Jeung HC, Choi HJ, Rha SY, Hyung WJ, Cheong JH, Noh SH, Chung HC. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute. J Surg Oncol 2007; 95: 461-468
20. Piso P, Bellin T, Aselmann H, Bektas H, Schlitt HJ, Klempnauer J. Results of combined gastrectomy and pancreatic resection in patients with advanced primary gastric carcinoma. Dig Surg 2002; 19: 281-285
21. Kaposztas Z, Kalmar K, Cseke L, Illenyi L, Kelemen D, Horvath OP. Prognostic factors in the surgical treatment of gastric cancer-10 years experience. Magy Seb 2007; 60: 71-78
22. Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet 1996; 347: 995-999
23. Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, van Elk P, Obertop H, Gouma DJ, Taat CW. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345: 745-748